Biora Therapeutics

BIOR62

Penny Stock

$1.67arrow_drop_down0.61%-$0.00

Penny Stock

BIOR62

$1.67

arrow_drop_down0.61%-$0.00

Penny Stock

Performance History

Key Stats
Open	$1.62
Prev. Close	$1.63
EPS	0.36
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$7.55M

	LOW	HIGH
Day Range	1.54	1.74
52 Week Range	0.47	5.17

Ratios

Revenue	-



EBITDA Margin %	-

EPS	0.36

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Biora Therapeutics (BIOR)

BIOR is the stock symbol for Biora Therapeutics, Inc., a biopharmaceutical company that focuses on the development and commercialization of innovative therapeutics for various diseases. BIOR has a history of fluctuating stock prices, which can be attributed to the volatile nature of the biotech industry. Investors should carefully analyze the stock's price history before making any investment decisions.

According to the latest quote, BIOR is currently trading at $X per share. This price reflects the market's perception of the company's potential and future prospects. It is important to note that stock prices can be influenced by various factors such as industry trends, company financials, and market sentiment.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Aditya P. Mohanty M.B.A.
Headquarters: San Diego
Employees: 54
Exchange: NASDAQ

Keep an eye on Biora Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Biora Therapeutics's (BIOR) price per share?

The current price per share for Biora Therapeutics (BIOR) is $1.67. The stock has seen a price change of -$0.01 recently, indicating a -0.61% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Biora Therapeutics (BIOR)?

For Biora Therapeutics (BIOR), the 52-week high is $5.17, which is 209.88% from the current price. The 52-week low is $0.47, the current price is 255.32% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Biora Therapeutics (BIOR) a growth stock?

Biora Therapeutics (BIOR) has shown an average price growth of -4.13% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biora Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Biora Therapeutics (BIOR) stock price performance year to date (YTD)?

As of the latest data, Biora Therapeutics (BIOR) has a year-to-date price change of -87.44%. Over the past month, the stock has experienced a price change of -56.74%. Over the last three months, the change has been -75.37%. Over the past six months, the figure is -66.4%.

help

Is Biora Therapeutics (BIOR) a profitable company?

Biora Therapeutics (BIOR) has a net income of -$124.12M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.96K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$67.14M. Furthermore, the EBITDA is -$67.51M.

help

What is the market capitalization of Biora Therapeutics (BIOR)?

Biora Therapeutics (BIOR) has a market capitalization of $7.55M. The average daily trading volume is 1.63, indicating the stock's liquidity and investor engagement.

News

BIORA THERAPEUTICS

BIOJET

ORAL DELIVERY

INGESTIBLE INJECTABLE

DRUG PAYLOAD

Oct 28, 2024

Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

BIORA THERAPEUTICS

H.C. WAINWRIGHT

GLOBAL INVESTMENT CONFERENCE

Aug 26, 2024

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

CALENDAR OF EVENTS

EARNINGS RELEASES AND OPERATING RESULTS

CONFERENCE CALLS/ WEBCASTS

May 15, 2024

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

CALENDAR OF EVENTS

CONFERENCE CALLS/ WEBCASTS